Cargando…

Trastuzumab in advanced breast cancer – a decade of experience in Germany

BACKGROUND: Trastuzumab was registered in 2000 for the treatment of metastatic breast cancer, both as monotherapy and combination therapy with paclitaxel. In this prospective, non-interventional observation study, the 10-year experience with trastuzumab in the routine management of HER2-positive bre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jackisch, Christian, Schoenegg, Winfried, Reichert, Dietmar, Welslau, Manfred, Selbach, Johannes, Harich, Hanns-Detlev, Tesch, Hans, Wohlfarth, Tim, Eustermann, Heidi, Hinke, Axel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295514/ https://www.ncbi.nlm.nih.gov/pubmed/25487774 http://dx.doi.org/10.1186/1471-2407-14-924

Ejemplares similares

Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer – results from the HER-OS patient registry
por: Witzel, Isabell, et al.
Publicado: (2014)

Subcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase
por: Shpilberg, O, et al.
Publicado: (2013)

Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study
por: Dall, Peter, et al.
Publicado: (2018)

Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer
por: Müller, Volkmar, et al.
Publicado: (2010)

Weekly paclitaxel plus trastuzumab in metastatic breast cancer pretreated with anthracyclines-a phase II multipractice study
por: John, Matthias, et al.
Publicado: (2012)

Romiplostim for Primary Immune Thrombocytopenia in Routine Clinical Practice: Results from a Multicentre Observational Study in Germany
por: Reiser, Marcel, et al.
Publicado: (2021)

White Paper on the Value of Time Savings for Patients and Healthcare Providers of Breast Cancer Therapy: The Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection as an Example
por: Jackisch, Christian, et al.
Publicado: (2022)

Identification of early molecular markers for breast cancer
por: Kretschmer, Céline, et al.
Publicado: (2011)

Is weight-based IV dosing of trastuzumab preferable to SC fixed-dose in some patients? A systematic scoping review
por: Kolberg, Hans-Christian, et al.
Publicado: (2021)

Gestational diabetes in Germany—prevalence, trend during the past decade and utilization of follow-up care: an observational study
por: Lappe, Veronika, et al.
Publicado: (2023)

Trastuzumab in Esophagogastric Cancer: HER2-Testing and Treatment Reality outside Clinical Studies in Germany
por: Merx, Kirsten, et al.
Publicado: (2016)

Decade of the Mind
por: Spitzer, Manfred
Publicado: (2008)

Clostridium difficile Surveillance Trends, Saxony, Germany
por: Burckhardt, Florian, et al.
Publicado: (2008)

Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine
por: Laakmann, Elena, et al.
Publicado: (2020)

A decade lost: does educational success mitigate the increased risks of premature death among children with experience of out-of-home care?
por: Almquist, Ylva B, et al.
Publicado: (2018)

Indication for spinal surgery: associated factors and regional differences in Germany
por: Tesch, Falko, et al.
Publicado: (2022)

Resistance to Trastuzumab
por: Vivekanandhan, Sneha, et al.
Publicado: (2022)

Crítica de la impaciencia revolucionaria ; seguido del anexo ¿Es la sociología una ciencia del hombre? : controversia radiofónica entre Theodor W. Adorno y Arnold Gehlen
por: Harich, Wolfgang
Publicado: (1988)

Correction: Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine
por: Laakmann, Elena, et al.
Publicado: (2020)

Capecitabine in the routine first-line treatment of elderly patients with advanced colorectal cancer - results from a non-interventional observation study
por: Stein, Alexander, et al.
Publicado: (2016)

Trastuzumab-induced thrombocytopenia after eight cycles of trastuzumab treatment
por: Zhou, Qiong, et al.
Publicado: (2020)

Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry
por: Egerer, Gerlinde, et al.
Publicado: (2012)

Learnability of a Configurator Empowering End Users to Create Mobile Data Collection Instruments: Usability Study
por: Schobel, Johannes, et al.
Publicado: (2018)

Revealing charge heterogeneity of stressed trastuzumab at the subunit level
por: Spanov, Baubek, et al.
Publicado: (2023)

Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice
por: Waller, Cornelius F., et al.
Publicado: (2021)

Short-Term Mortality Rates during a Decade of Improved Air Quality in Erfurt, Germany
por: Breitner, Susanne, et al.
Publicado: (2009)

A decade of fluvial morphodynamics: relocation and restoration of the Inde River (North-Rhine Westphalia, Germany)
por: Maaß, Anna-Lisa, et al.
Publicado: (2018)

Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA(†)
por: Krop, I. E., et al.
Publicado: (2015)

Resistance to Mecillinam and Nine Other Antibiotics for Oral Use in Escherichia coli Isolated from Urine Specimens of Primary Care Patients in Germany, 2019/20
por: Kresken, Michael, et al.
Publicado: (2022)

Immune Effects of Trastuzumab
por: Nuti, Marianna, et al.
Publicado: (2011)

Importation of Human Seoul Virus Infection to Germany from Indonesia
por: Hofmann, Jörg, et al.
Publicado: (2018)

Socioeconomic influence on treatment and outcome of patients with oral cancer in Germany
por: Klingelhöffer, Christoph, et al.
Publicado: (2021)

Efficacy and Safety of Trastuzumab Emtansine Plus Capecitabine vs Trastuzumab Emtansine Alone in Patients With Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Phase 1 and Randomized Phase 2 Trial
por: Cortés, Javier, et al.
Publicado: (2020)

Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit
por: Triulzi, Tiziana, et al.
Publicado: (2018)

Hantavirus Outbreak, Germany, 2007
por: Hofmann, Jörg, et al.
Publicado: (2008)

Standard reference values of the upper body posture in healthy young female adults in Germany: an observational study
por: Ohlendorf, Daniela, et al.
Publicado: (2018)

Socio-economic deprivation and COVID-19 in Germany
por: Moissl, Angela P., et al.
Publicado: (2022)

Pertuzumab, Trastuzumab, and an Aromatase Inhibitor for HER2-Positive and Hormone Receptor–Positive Metastatic or Locally Advanced Breast Cancer: PERTAIN Final Analysis
por: Arpino, Grazia, et al.
Publicado: (2023)

Trends in survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century
por: Pulte, Dianne, et al.
Publicado: (2016)

Decentralized colorectal cancer care in Germany over the last decade is associated with high in-hospital morbidity and mortality
por: Ghadban, Tarik, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t1qhevpdmmflg14llrp3ter3b2